Day One Biopharmaceuticals
DAWN
#6170
Rank
$0.88 B
Marketcap
$8.60
Share price
8.59%
Change (1 day)
-36.15%
Change (1 year)

Revenue for Day One Biopharmaceuticals (DAWN)

Revenue in 2025 (TTM): $0.13 Billion USD

According to Day One Biopharmaceuticals's latest financial reports the company's current revenue (TTM ) is $0.13 Billion USD. In 2024 the company made a revenue of $0.13 Billion USD an increase over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Day One Biopharmaceuticals from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) $0.13 B1.91%
2024 $0.13 B
2023 N/A
2022 N/A
2021 N/A
2020 N/A